Advancing Management of Chronic Hepatitis B

Join us as we explore the changing chronic hepatitis B landscape, with a focus on how emerging approaches to disease evaluation can optimize patient outcomes. This session will examine evolving concepts in comprehensive assessment that may influence testing and treatment decisions. Industry Supporter: GlaxoSmithKline, LLC